3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with meglumine in 1 studies
Studies (3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate) | Trials (3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate) | Recent Studies (post-2010) (3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate) | Studies (meglumine) | Trials (meglumine) | Recent Studies (post-2010) (meglumine) |
---|---|---|---|---|---|
420 | 1 | 143 | 4,168 | 413 | 1,399 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drummond, RM; Petrou, S; Singer, JJ; Ugur, M; Walsh, JV | 1 |
1 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and meglumine
Article | Year |
---|---|
P2X7 purinoceptor expression in Xenopus oocytes is not sufficient to produce a pore-forming P2Z-like phenotype.
Topics: Adenosine Triphosphate; Animals; Benzoxazoles; Cell Membrane Permeability; Electrophysiology; Fluorescent Dyes; Gene Expression; Ion Channels; Meglumine; Microinjections; Oocytes; Patch-Clamp Techniques; Phenotype; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Recombinant Proteins; RNA, Complementary; Xenopus | 1997 |